to the Company and MERCURIA; however, this transaction is expected to be completed within November 2017 The Company will updated and disclose the progress of this transaction to the Stock Exchange of
the progress of this transaction to the Stock Exchange of Thailand from time to time. 2. Related parties and their relationships with the Company Buyer: Mercuria Investment Co., Ltd. (“MERCURIA”) or any
of customers, the target customers, the project value, the sale and construction progress, etc. Describe the research and development policy in areas and specify the details of the process of
and construction progress, etc. Describe the research and development policy in areas and specify the details of the process of innovative development, products and/or services o r the business model
/2563 2.1543 3.4271 5.5814 246003662005-1 HUMAN WASATCH ADVISORS, INC. จำหน่าย หุ้น 5.8926 0.9036 4.989 13/02/2563 5.8926 0.9036 4.989 246002552002-1 HUMAN CAPITAL RESEARCH AND MANAGEMENT COMPANY
professionals, especially securities analysts, to attain better knowledge and deeper learning of ESG data analysis and integrate this information into their research reports. In addition, the emphasis on ESG in
Co., Ltd., (2) Diamond and Silverline Group Co., Ltd., (3) K.N.O. Marketing Co., Ltd., (4) M.B. Network Co., Ltd., and (5) P.T. Research Co., Ltd., along with four related persons, namely (1) Jaray
Laboratory and Research Center (“AMARC”). Costs and Expenses The Company reported the consolidated costs and expenses for Q1/2019 of Baht 345.54 million, nearby of Q1/2018 of Baht 345.61 million decreased by
booked in year 2018 for chronic diseases were then subtracted accordingly. However, the service revenues (mainly received from Asia Medical and Agricultural Laboratory and Research Center Co., Ltd “AMARC